...as a recombinant protein, which presents the antigen seven times to the immune system. Imaxio’s MVA85A-IMX313...

...the University of Oxford (Oxford, U.K.) formed JV OETC in 2008 to develop the university's MVA85A...
...prevent TB. Emergent said it and OETC ceased development of the vaccine last year after MVA85A...
...TB vaccines under a grant from NIH's National Institute of Allergy and Infectious Diseases (NIAID). MVA85A...

...Oxford University began a single-blind, dose-escalation, U.K. Phase I trial to evaluate intradermal MVA85A-IMX313 vs. MVA85A...
...30 healthy Bacille Calmette-Guerin (BCG)-vaccinated healthy volunteers ages 18-55. Imaxio S.A. , Saint-Beauzire, France Product: MVA85A-IMX313...

...in futility analyses of the Phase III FLEX-M and FLEX-V trials Emergent BioSolutions Inc. (NYSE:EBS) MVA85A...

...Clinical milestones Emergent BioSolutions Inc. (NYSE:EBS) was off $0.60 to $15.70 last week after MVA85A...
...the incidence of tuberculosis infection vs. placebo in a Phase IIb trial to prevent TB. MVA85A...

...were vaccinated with Bacille Calmette-Guerin (BCG) at birth showed that a single intradermal dose of MVA85A...
...follow-up of 24.6 months. Specifically, there were 32 cases (2%) of TB in infants receiving MVA85A...
...Md. Aeras Global TB Vaccine Foundation , Rockville, Md. Product: Tuberculosis vaccine ( MVA85A/AERAS-485 , MVA85A...

...Emergent BioSolutions Inc. (NYSE:EBS) said a single intradermal dose of MVA85A missed the primary efficacy endpoint...
...trial to prevent TB. Specifically, there were 32 cases (2%) of TB in infants receiving MVA85A...
...vaccines are used to vaccinate against TB infection, but they do not prevent pulmonary TB. MVA85A...

...NIH's National Institute of Allergy and Infectious Diseases (NIAID) to develop tuberculosis (TB) vaccine candidate MVA85A...
...Tuberculosis Consortium Ltd., a joint venture between Emergent and the University of Oxford (Oxford, U.K.). MVA85A...

...advanced are MVA85A and AERAS-402/Crucell Ad35 , both of which are in Phase IIb testing. MVA85A...

...advanced are MVA85A and AERAS-402/Crucell Ad35 , both of which are in Phase IIb testing. MVA85A...